HAVRIX PEDIATRIC READY-TO-USE INJECTOR WITH SUSPENSION FOR IM INJECTION 720 EU/0.5 ml

Hepatitis A (inactivated) vaccine, adsorbed

Active ingredient: One dose (0.5 mL) contains the following active ingredient. Hepatitis A virus (inactivated) 1.2 720 ELISA Units

1 Produced in human diploid (MRC5) cells

2 Adsorbed to aluminum hydroxide, hydrated Total 0.25 mg Al3+

HAVRIX PEDIATRIC is used to prevent hepatitis A disease in children and adolescents between the ages of 1-15 (15 years included). The vaccine works by causing the body to create its own protection system (antibodies) against this disease. It takes 2-4 weeks for protective antibodies against hepatitis A to form.

Hepatitis A is an infectious disease that can affect the liver. This disease is caused by the hepatitis A virus. Hepatitis A virus can be transmitted from person to person through food, drink or swimming in water contaminated with wastewater. Hepatitis A symptoms begin to appear within 3-6 weeks after contact with the virus. These symptoms are nausea, fever, aches and pains. After a few days, yellowing of the white parts of the eyes and skin (jaundice) may occur. The severity and type of symptoms may vary. Jaundice may not be observed in young children. Many individuals can fully recover; However, this disease is serious enough to make individuals sick for about 1 month.

Vaccination is the best way to protect against this disease. None of the ingredients in the vaccine are contagious.

Getting this vaccine only protects against hepatitis A. It is ineffective against other types of hepatitis viruses and other diseases that cause liver inflammation.

HAVRIX PEDIATRIC is presented in a ready-to-use glass syringe (0.5 mL) containing a suspension for injection.

Instructions for proper use and dosage/frequency of administration

HAVRIX PEDIATRIC is used in children between the ages of 1-15 (15 years included).

You/your child will be given 1 dose of HAVRIX PEDIATRIC (0.5 mL suspension).

The second (booster) dose can be given at any time between six months and five years, but is preferably administered between six months and twelve months following the administration of the first dose to ensure long-term protection.

Your doctor will administer HAVRIX PEDIATRIC as an injection into your child’s upper arm muscle or into the thigh muscle in younger children.

Like all medicines, side effects may occur in people who are sensitive to the ingredients contained in HAVRIX PEDIATRIC.

If any of the following occur, stop using HAVRIX PEDIATRIC and IMMEDIATELY inform your doctor or go to the emergency department of your nearest hospital:

As with any vaccine administered by injection, there is a rare risk of allergic reactions. Allergy signs may include a local or widespread itchy or blistered skin rash that may progress to worsening, swelling of the eyes and face, and difficulty breathing or swallowing. If these signs occur, contact your doctor immediately.

Side effects are listed as shown in the categories below.

If any of the side effects become serious in you or your child, please inform your doctor or pharmacist.

⚠️ Disclaimer: The information provided on this website is for informational purposes only and does not substitute professional medical advice. Always consult a healthcare provider before using any medication.